X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20564) 20564
Book Chapter (167) 167
Dissertation (112) 112
Publication (31) 31
Magazine Article (29) 29
Book / eBook (17) 17
Conference Proceeding (16) 16
Government Document (14) 14
Web Resource (11) 11
Book Review (6) 6
Reference (3) 3
Newsletter (1) 1
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (11855) 11855
humans (10985) 10985
animals (6772) 6772
aromatase (5965) 5965
aromatase inhibitors (5094) 5094
male (4850) 4850
breast cancer (4359) 4359
oncology (4080) 4080
endocrinology & metabolism (3948) 3948
aromatase - metabolism (3805) 3805
breast neoplasms - drug therapy (3775) 3775
estrogen (3553) 3553
postmenopausal women (3030) 3030
middle aged (2793) 2793
aromatase - genetics (2624) 2624
tamoxifen (2613) 2613
adult (2392) 2392
aromatase inhibitors - therapeutic use (2317) 2317
aged (2162) 2162
estradiol (2067) 2067
aromatase inhibitor (2036) 2036
expression (1995) 1995
biochemistry & molecular biology (1940) 1940
cancer (1930) 1930
testosterone (1861) 1861
rats (1817) 1817
letrozole (1696) 1696
breast neoplasms - pathology (1637) 1637
obstetrics & gynecology (1509) 1509
women (1492) 1492
antineoplastic agents, hormonal - therapeutic use (1472) 1472
analysis (1410) 1410
anastrozole (1404) 1404
pregnancy (1368) 1368
mice (1361) 1361
reproductive biology (1351) 1351
endocrine therapy (1246) 1246
tamoxifen - therapeutic use (1235) 1235
postmenopause (1221) 1221
gene expression (1204) 1204
care and treatment (1152) 1152
breast neoplasms - metabolism (1143) 1143
estrogens (1129) 1129
research (1126) 1126
gene-expression (1104) 1104
pharmacology & pharmacy (1096) 1096
triazoles - therapeutic use (1095) 1095
nitriles - therapeutic use (1092) 1092
aromatase inhibitors - pharmacology (1074) 1074
breast-cancer (1065) 1065
aromatase-activity (1059) 1059
treatment outcome (1027) 1027
randomized-trial (1011) 1011
cells, cultured (987) 987
estradiol - blood (963) 963
aromatase inhibitors - adverse effects (956) 956
medicine & public health (954) 954
neurosciences (947) 947
receptors, estrogen - metabolism (943) 943
immunohistochemistry (933) 933
health aspects (918) 918
therapy (917) 917
chemotherapy, adjuvant (871) 871
risk factors (865) 865
estrogens - metabolism (854) 854
androgens (851) 851
toxicology (846) 846
hormones (836) 836
aged, 80 and over (834) 834
brain (823) 823
enzymes (822) 822
cell biology (819) 819
rna, messenger - metabolism (787) 787
antineoplastic agents - therapeutic use (785) 785
dose-response relationship, drug (783) 783
estradiol - metabolism (783) 783
physiological aspects (781) 781
cells (768) 768
estradiol - pharmacology (758) 758
testosterone - blood (745) 745
cytochrome p-450 (742) 742
chemotherapy (723) 723
estrogen-receptor (716) 716
breast neoplasms - genetics (706) 706
progesterone (691) 691
in-vitro (670) 670
aromatase inhibitors - administration & dosage (664) 664
cell line, tumor (661) 661
time factors (658) 658
menopause (653) 653
exemestane (646) 646
testosterone - metabolism (644) 644
enzyme inhibitors - pharmacology (636) 636
breast neoplasms - enzymology (634) 634
triazoles - pharmacology (628) 628
growth (626) 626
estrogens - biosynthesis (624) 624
metabolism (618) 618
messenger-rna (613) 613
risk (587) 587
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20015) 20015
Japanese (342) 342
French (252) 252
German (185) 185
Chinese (81) 81
Russian (71) 71
Spanish (58) 58
Portuguese (55) 55
Polish (36) 36
Italian (33) 33
Korean (31) 31
Hungarian (18) 18
Czech (14) 14
Danish (9) 9
Swedish (9) 9
Romanian (7) 7
Dutch (6) 6
Slovak (6) 6
Bulgarian (3) 3
Finnish (3) 3
Norwegian (3) 3
Turkish (3) 3
Ukrainian (3) 3
Arabic (2) 2
Croatian (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Persian (2) 2
Slovenian (2) 2
Bosnian (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of steroid biochemistry and molecular biology, ISSN 0960-0760, 2016, Volume 161, pp. 73 - 83
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 5, p. e36069
The tg(cyp19a1b-GFP) transgenic zebrafish expresses GFP (green fluorescent protein) under the control of the cyp19a1b gene, encoding brain aromatase. This gene... 
ANDROGEN RECEPTOR | RADIAL GLIAL-CELLS | BRAIN AROMATASE GENE | BIOLOGY | WILDLIFE | ALPHA | BISPHENOL-A | FATHEAD MINNOW | KNOCKOUT MICE | EXPRESSION | BINDING | Green Fluorescent Proteins - metabolism | Estradiol - analogs & derivatives | Animals, Genetically Modified | Zebrafish Proteins - metabolism | Estradiol Congeners - pharmacology | Embryonic Development - genetics | Gene Expression Regulation, Developmental - drug effects | Aromatase - metabolism | Green Fluorescent Proteins - genetics | Zebrafish - embryology | Zebrafish - genetics | Aromatase - genetics | Molecular Mimicry | Neuroglia - cytology | Animals | Neuroglia - metabolism | Zebrafish Proteins - genetics | Estradiol - pharmacology | Endocrine disruptors | Embryonic development | Androgens | Estrogen | Stem cells | Fluorescence | Animal genetic engineering | Cytochrome | Reproductive health | Neuroimaging | Drugs | Brain | Laboratories | Estrogens | Cognitive ability | Transgenic | Radial glial cells | Hormones | Glial cells | Glial stem cells | Xenoestrogens | Metabolites | Risk assessment | Rodents | Aromatase | Trends | Endocrine system | Bioassays | Attention | Cell division | Zebrafish | Gene expression | Medical screening | Embryos | Environmental impact | Chemicals | Studies | Green fluorescent protein | Molecular biology | Animal cognition | Green Fluorescent Proteins | Neuroglia | Zebrafish Proteins | Embryonic Development | Estradiol | Life Sciences | Gene Expression Regulation, Developmental | Estradiol Congeners | Reproductive Biology
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 6, pp. 520 - 529
Resistance to hormone therapy through activation of cellular pathways involving mTOR can develop in postmenopausal hormone-receptor–positive breast cancer.... 
TRIAL | WOMEN | MEDICINE, GENERAL & INTERNAL | EFFICACY | TAMOXIFEN | PHASE-III | LETROZOLE | SUPERIOR | AROMATASE INHIBITORS | FIRST-LINE THERAPY | ANASTROZOLE | Recurrence | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bone Neoplasms - secondary | TOR Serine-Threonine Kinases - antagonists & inhibitors | Aromatase Inhibitors - adverse effects | Breast Neoplasms - chemistry | Aged, 80 and over | Postmenopause | Adult | Female | Aromatase Inhibitors - therapeutic use | Everolimus | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Kaplan-Meier Estimate | Receptor, Epidermal Growth Factor - analysis | Breast Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Stomatitis - chemically induced | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Drugs | Care and treatment | Usage | Hormone therapy | Patient outcomes | Drug utilization | Breast cancer | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | TOR protein | Anastrozole | Endocrine therapy | Fatigue | Intracellular signalling | Rapamycin | Tamoxifen | Cancer therapies | Survival | Post-menopause | Fulvestrant | Signal transduction | Stomatitis | Hyperglycemia | Chemotherapy | Pneumonitis | Dyspnea | Aromatase | Antitumor activity | Respiration
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2010, Volume 124, Issue 1, pp. 89 - 99
Resistance to endocrine therapy agents has presented a clinical obstacle in the treatment of hormone-dependent breast cancer. Our laboratory has initiated a... 
TGFβ | MicroRNA | Aromatase inhibitor resistance | MiR-128a | Estrogen | TUMOR INVASION | FACTOR-BETA | TAMOXIFEN RESISTANCE | RANDOMIZED-TRIAL | AROMATASE-TRANSFECTED MCF-7 | ONCOLOGY | ESTROGEN-RECEPTOR-ALPHA | C-ELEGANS | TRANSFORMING-GROWTH-FACTOR | TGF beta | POSTMENOPAUSAL WOMEN | INHIBITOR | Receptors, Transforming Growth Factor beta - genetics | Nitriles - pharmacology | Oligonucleotide Array Sequence Analysis | Aromatase Inhibitors - pharmacology | Humans | Transforming Growth Factor beta1 - metabolism | Aromatase - metabolism | Molecular Sequence Data | MicroRNAs - metabolism | Breast Neoplasms - metabolism | Testosterone - metabolism | Aromatase - genetics | Transfection | Female | Antineoplastic Agents - pharmacology | 3' Untranslated Regions | Binding Sites | Protein-Serine-Threonine Kinases - metabolism | Estradiol - metabolism | Protein-Serine-Threonine Kinases - genetics | Gene Expression Profiling - methods | Triazoles - pharmacology | Drug Resistance, Neoplasm - genetics | Breast Neoplasms - genetics | Receptors, Transforming Growth Factor beta - metabolism | Signal Transduction - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Cell Proliferation - drug effects | Care and treatment | DNA microarrays | Analysis | Development and progression | Breast cancer | Genetic transcription | Tamoxifen | Transforming growth factors | Protein binding | 3' Untranslated regions | microRNA | miR-128a | Aromatase Inhibitor Resistance
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 25, pp. 2381 - 2391
Journal Article
Journal Article